Cancer and insulin-like growth factor-I. A potential mechanism linking the environment with cancer risk.
作者信息
Smith G D, Gunnell D, Holly J
出版信息
BMJ. 2000 Oct 7;321(7265):847-8. doi: 10.1136/bmj.321.7265.847.
Abstract
摘要
相似文献
1
Cancer and insulin-like growth factor-I. A potential mechanism linking the environment with cancer risk.癌症与胰岛素样生长因子-I。一种将环境与癌症风险联系起来的潜在机制。
BMJ. 2000 Oct 7;321(7265):847-8. doi: 10.1136/bmj.321.7265.847.
2
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis.胰岛素样生长因子（IGF）-I、IGF结合蛋白-3与癌症风险：系统评价和meta回归分析
Lancet. 2004 Apr 24;363(9418):1346-53. doi: 10.1016/S0140-6736(04)16044-3.
3
Beyond steroid hormones: the new cancer endocrinology.超越甾体激素：新的癌症内分泌学。
Lancet Oncol. 2010 Jun;11(6):501-2. doi: 10.1016/S1470-2045(10)70116-9. Epub 2010 May 14.
4
Plasma insulin-like growth factor 1, insulin-like growth factor binding protein 3, and risk of colorectal cancer: a prospective study in northern Sweden.血浆胰岛素样生长因子1、胰岛素样生长因子结合蛋白3与结直肠癌风险：瑞典北部的一项前瞻性研究
Gut. 2002 May;50(5):642-6. doi: 10.1136/gut.50.5.642.
5
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and breast cancer risk: eight years on.胰岛素样生长因子（IGF）-I、IGF结合蛋白-3与乳腺癌风险：八年随访研究
Endocr Relat Cancer. 2006 Jun;13(2):273-8. doi: 10.1677/erc.1.01219.
6
7
8
[Prostatic cancer? Breast cancer? Do you know your serum IGF-I?].[前列腺癌？乳腺癌？你了解自己的血清胰岛素样生长因子-I吗？]
Ugeskr Laeger. 1998 Jul 27;160(31):4541-2.
9
10
Factors associated with circulating levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3 in 740 women at risk for breast cancer.740名乳腺癌高危女性中与胰岛素样生长因子-I及胰岛素样生长因子结合蛋白-3循环水平相关的因素。
Breast Cancer Res Treat. 2004 Nov;88(1):63-73. doi: 10.1007/s10549-004-0746-9.
引用本文的文献
1
Protein Quantity and Source, Fasting-Mimicking Diets, and Longevity.蛋白质的数量和来源、禁食模拟饮食与长寿。
Adv Nutr. 2019 Nov 1;10(Suppl_4):S340-S350. doi: 10.1093/advances/nmz079.
2
Fasting and Caloric Restriction in Cancer Prevention and Treatment.禁食与热量限制在癌症预防和治疗中的作用
Recent Results Cancer Res. 2016;207:241-66. doi: 10.1007/978-3-319-42118-6_12.
3
Metabolic syndrome is associated with better prognosis in patients with tongue squamous cell carcinoma.代谢综合征与舌鳞状细胞癌患者的较好预后相关。
Chin J Cancer. 2015 Apr 8;34(4):184-8. doi: 10.1186/s40880-015-0009-7.
4
Safety, tolerability, and pharmacokinetics of single and multiple doses of intravenous cixutumumab (IMC-A12), an inhibitor of the insulin-like growth factor-I receptor, administered weekly or every 2 weeks in patients with advanced solid tumors.在晚期实体瘤患者中，每周或每2周静脉注射单剂量和多剂量胰岛素样生长因子-I受体抑制剂西妥昔单抗（IMC-A12）的安全性、耐受性和药代动力学。
Invest New Drugs. 2015 Apr;33(2):450-62. doi: 10.1007/s10637-015-0217-7. Epub 2015 Mar 7.
5
Serum glucose and risk of cancer: a meta-analysis.血清葡萄糖与癌症风险：一项荟萃分析。
BMC Cancer. 2014 Dec 19;14:985. doi: 10.1186/1471-2407-14-985.
6
Incidence of second malignancies for prostate cancer.前列腺癌继发恶性肿瘤的发病率。
PLoS One. 2014 Jul 21;9(7):e102596. doi: 10.1371/journal.pone.0102596. eCollection 2014.
7
Metastatic Renal Cancer: What Role for Everolimus?转移性肾癌：依维莫司有何作用？
Clin Med Rev Oncol. 2010 Feb 18;2:4. doi: 10.4137/CMRO.S1551.
8
Relationship between Metabolic Syndrome and History of Cervical Cancer among a US National Population.美国全国人口中代谢综合征与宫颈癌病史之间的关系。
ISRN Oncol. 2013;2013:840964. doi: 10.1155/2013/840964. Epub 2013 Jan 21.
9
Insulin-like growth factor-1 and childhood cancer risk.胰岛素样生长因子-1与儿童癌症风险
Oncol Lett. 2010 Nov;1(6):1055-1059. doi: 10.3892/ol.2010.169. Epub 2010 Sep 8.
10
Magneto-optical relaxation measurements of functionalized nanoparticles as a novel biosensor.基于功能化纳米颗粒的磁光弛豫测量的新型生物传感器。
Sensors (Basel). 2009;9(6):4022-33. doi: 10.3390/s90604022. Epub 2009 May 26.
本文引用的文献
1
Cancer in acromegaly.肢端肥大症中的癌症。
Trends Endocrinol Metab. 1998 Nov;9(9):360-6. doi: 10.1016/s1043-2760(98)00093-9.
2
Height, insulin-like growth factors and cancer risk.身高、胰岛素样生长因子与癌症风险。
Growth Horm IGF Res. 2000 Apr;10 Suppl A:S39-40. doi: 10.1016/s1096-6374(00)90019-4.
3
Environmental and heritable factors in the causation of cancer--analyses of cohorts of twins from Sweden, Denmark, and Finland.癌症病因中的环境与遗传因素——对瑞典、丹麦和芬兰双胞胎队列的分析
N Engl J Med. 2000 Jul 13;343(2):78-85. doi: 10.1056/NEJM200007133430201.
4
Joint effect of insulin-like growth factors and mutagen sensitivity in lung cancer risk.胰岛素样生长因子与诱变敏感性对肺癌风险的联合影响。
J Natl Cancer Inst. 2000 May 3;92(9):737-43. doi: 10.1093/jnci/92.9.737.
5
Height and risk of death among men and women: aetiological implications of associations with cardiorespiratory disease and cancer mortality.男性和女性的身高与死亡风险：与心血管疾病和癌症死亡率关联的病因学意义
J Epidemiol Community Health. 2000 Feb;54(2):97-103. doi: 10.1136/jech.54.2.97.
6
Insulin-like growth factor 1 (IGF-1), IGF-1 density, and IGF-1/PSA ratio for prostate cancer detection.
Urology. 1999 Oct;54(4):603-6. doi: 10.1016/s0090-4295(99)00280-0.
7
Growth hormone, IGF-I and cancer. Less intervention to avoid cancer? More intervention to prevent cancer?生长激素、胰岛素样生长因子-I与癌症。减少干预以避免患癌？还是增加干预以预防癌症？
J Endocrinol. 1999 Sep;162(3):321-30. doi: 10.1677/joe.0.1620321.
8
Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.男性结直肠癌风险与胰岛素样生长因子（IGF）-I及IGF结合蛋白-3血浆水平的前瞻性研究
J Natl Cancer Inst. 1999 Apr 7;91(7):620-5. doi: 10.1093/jnci/91.7.620.
9
Insulin-like growth factor-I and binding protein-3 in relation to childhood leukaemia.胰岛素样生长因子-I及结合蛋白-3与儿童白血病的关系
Int J Cancer. 1999 Feb 9;80(4):494-6. doi: 10.1002/(sici)1097-0215(19990209)80:4<494::aid-ijc2>3.0.co;2-k.
10
Circulating concentrations of insulin-like growth factor-I and risk of breast cancer.胰岛素样生长因子-I的循环浓度与乳腺癌风险
Lancet. 1998 May 9;351(9113):1393-6. doi: 10.1016/S0140-6736(97)10384-1.
Zotero 插件